Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 16,98117,000 of 20,252 grants

Active NON-SBIR/STTR RPGS
Project 3 – Stromal derived IL-6/STAT3 signaling in the development and progression of PDAC
NATIONAL CANCER INSTITUTE Medical University of South Carolina United States 2021 – 2026

PROJECT SUMMARY: PROJECT 3 PDAC is among the most deadly malignant solid tumors, with approximately 92% of patients succumbing to the disease within five years of diagnosis, and wi...

Active NON-SBIR/STTR RPGS
Core A - Administration
NATIONAL CANCER INSTITUTE Medical University of South Carolina United States 2021 – 2026

PROEJCT SUMMARY: CORE A The Administrative Core will provide centralized grant administration, data processing and administrative support for the projects. This Core will also serv...

Active NON-SBIR/STTR RPGS
Core B – Human Biospecimen and Advanced Sequencing Core
NATIONAL CANCER INSTITUTE Medical University of South Carolina United States 2021 – 2026

PROJECT SUMMARY: CORE B The goal of this Program is to advance knowledge of pancreatic ductal adenocarcinoma (PDAC), a recalcitrant cancer with one of the highest rates of cachexia...

Active NON-SBIR/STTR RPGS
Core C – Immunophenotyping Core
NATIONAL CANCER INSTITUTE Medical University of South Carolina United States 2021 – 2026

SUMMARY: CORE C Cachexia is a wasting syndrome that significantly contributes to the morbidity and mortality of cancer patients, especially those diagnosed with pancreatic ductal a...

Active NON-SBIR/STTR RPGS
Core D – Biostatistics Core
NATIONAL CANCER INSTITUTE Medical University of South Carolina United States 2021 – 2026

SUMMARY: CORE D The Biostatistics Core provides centralized and state-of-the-art support to meet the data management and analytic needs of the Program Project Grant. Core personnel...

Active NON-SBIR/STTR RPGS
Adapting and implementing evidence-based breast cancer follow-up in primary care
NATIONAL CANCER INSTITUTE Rutgers Biomedical and Health Sciences United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Breast cancer survivors are a growing population and their symptom burden is significant. Despite growing evidence on specific symptoms and risk management...

$6.19M
USD
Completed NON-SBIR/STTR RPGS
Pre-Clinical Core
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2021 – 2026

CORE 2 PROJECT SUMMARY PRECLINICAL MODELS AND PATHOLOGY CORE The Preclinical Core (Core #2) leverages the knowledge and expertise from several Moffitt investigators and core facili...

Completed NON-SBIR/STTR RPGS
Metabolomics Core
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2021 – 2026

CORE 3 PROJECT SUMMARY METABOLISM CORE The Metabolism Core (Core #3) supports the metabolomics and proteomics experiments designed by program project grant (PPG) investigators as i...

Completed NON-SBIR/STTR RPGS
Data Science Core
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2021 – 2026

CORE 4 PROJECT SUMMARY DATA SCIENCE CORE The mission of the Data Science Core (Core #4) is to serve as the focal point from which Program Project investigators can draw statistical...

Completed NON-SBIR/STTR RPGS
Identifying Metabolic Vulnerabilities in Lung Cancer
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2021 – 2026

OVERALL PROJECT SUMMARY IDENTIFYING METABOLIC VULNERABILITIES IN LUNG CANCER Lung Cancer is the most common cause of cancer deaths world-wide. Tyrosine kinase inhibitors and immuno...

$20.19M
USD
Completed NON-SBIR/STTR RPGS
Project 1
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2021 – 2026

PROJECT 1 SUMMARY IDENTIFYING METABOLIC VULNERABILITIES REGULATED BY THE P53 FAMILY IN LUNG CANCER p53 is commonly mutated in all subtypes of human lung cancer. p53 is part of a fa...

Completed NON-SBIR/STTR RPGS
Project 1
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2021 – 2026

PROJECT 1 SUMMARY IDENTIFYING METABOLIC VULNERABILITIES REGULATED BY THE P53 FAMILY IN LUNG CANCER p53 is commonly mutated in all subtypes of human lung cancer. p53 is part of a fa...

Completed NON-SBIR/STTR RPGS
Project 2
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2021 – 2026

PROJECT 2 SUMMARY INVESTIGATING CYSTEINE ESSENTIALITY IN LUNG CANCER Cancer cells accumulate significant intracellular cysteine due to increased cystine uptake and loss of homeosta...

Completed NON-SBIR/STTR RPGS
Identifying Metabolic Vulnerabilities in Lung Cancer
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2021 – 2026

OVERALL PROJECT SUMMARY IDENTIFYING METABOLIC VULNERABILITIES IN LUNG CANCER Lung Cancer is the most common cause of cancer deaths world-wide.Tyrosine kinase inhibitors and immunot...

$20.6M
USD
Completed NON-SBIR/STTR RPGS
Project 2
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2021 – 2026

PROJECT 2 SUMMARY INVESTIGATING CYSTEINE ESSENTIALITY IN LUNG CANCER Cancer cells accumulate significant intracellular cysteine due to increased cystine uptake and loss of homeosta...

Completed NON-SBIR/STTR RPGS
Project 3
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2021 – 2026

PROJECT 3 SUMMARY ROLES AND MECHANISMS OF ACTION OF METABOLIC VULNERABILITIES OF SCLC Small cell lung cancer (SCLC) lacks targeted therapies, and with only 7% overall survival on s...

Completed NON-SBIR/STTR RPGS
Project 1
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2021 – 2026

PROJECT 1 SUMMARY IDENTIFYING METABOLIC VULNERABILITIES REGULATED BY THE P53 FAMILY IN LUNG CANCER p53 is commonly mutated in all subtypes of human lung cancer. p53 is part of a fa...

Completed NON-SBIR/STTR RPGS
Project 2
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2021 – 2026

PROJECT 2 SUMMARY INVESTIGATING CYSTEINE ESSENTIALITY IN LUNG CANCER Cancer cells accumulate significant intracellular cysteine due to increased cystine uptake and loss of homeosta...

Completed NON-SBIR/STTR RPGS
Project 3
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2021 – 2026

PROJECT 3 SUMMARY ROLES AND MECHANISMS OF ACTION OF METABOLIC VULNERABILITIES OF SCLC Small cell lung cancer (SCLC) lacks targeted therapies, and with only 7% overall survival on s...

Completed NON-SBIR/STTR RPGS
Project 4
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2021 – 2026

PROJECT 4 SUMMARY: METABOLIC AND FUNCTIONAL REPROGRAMMING OF IMMUNOSUPPRESSIVE MYELOPOIESIS IN LUNG TUMORS Lung cancer cells and tumor-infiltrating immune subsets activate an integ...